Adcock shareholder on defense for opposing buyout by CFR

The largest shareholder for South Africa's Adcock Ingram is defending its opposition to the drugmaker being bought by CFR after Abbott ($ABT) bought Chile-based CFR for $3 billion. Adcock continues to face financial challenges that could have been sorted out by the merger, some contend. Story